CERVICAL CANCER

This study tests a new vaccine called PVX7 in 32 women with advanced cervical cancer who have finished their main treatment. The goal is to see if the vaccine is safe and can boost the body's immune response against the HPV virus that causes the cancer. Participants will receive …

This study tests a new drug called HLX43 in about 190 women with cervical or ovarian cancer that has come back or spread and did not respond to standard first treatment. The drug is designed to target and kill cancer cells. The goal is to see if it can shrink tumors and slow dise…

This study tests a new drug, MGC026, in 250 adults with advanced solid tumors that have not responded to other treatments. The goal is to check the drug's safety, find the right dose, and see if it can shrink tumors. Participants receive the drug by IV and are closely monitored f…

This study tests a newer type of radiation therapy called online adaptive radiotherapy (oART) for people with cervical cancer. The goal is to see if oART causes fewer side effects and controls the tumor better than standard image-guided radiotherapy. About 124 adults aged 18-80 w…

This study tests a drug called sacituzumab govitecan in 20 people whose cervical cancer has returned or not improved after at least one prior treatment. The drug works like a guided missile, delivering chemotherapy directly to cancer cells. The main goal is to see how many patien…

This study tests a combination of two or three drugs (BL-B01D1, pembrolizumab, and possibly bevacizumab) in people whose cervical or endometrial cancer has returned or spread. The goal is to see if these drugs can shrink tumors or slow the disease. About 96 adults aged 18–75 with…

This study tests a new treatment called KD01, a modified virus that targets and kills cancer cells, for women with cervical or endometrial cancer. In Phase I, it is given to patients whose cancer has not responded to other treatments. In Phase II, it is tested in younger women wh…

This study tests a new drug combination (sacituzumab tirumotecan plus pembrolizumab, with or without bevacizumab) as a first maintenance treatment for people with metastatic cervical cancer that has spread. About 1,000 participants will be randomly assigned to the new combo or st…

This study tests a combination of two drugs, pembrolizumab and lenvatinib, in people with advanced cervical cancer that has not responded to initial treatment. The goal is to see if this combination can shrink tumors or slow cancer growth. About 35 participants will receive the t…

This study tests a new immunotherapy for people with advanced HPV-related cancers (cervical, throat, anal, and others). Doctors take a patient's own immune cells, add a special receptor to help them find and attack HPV-infected cancer cells, and give them back. The goal is to shr…

This early-phase trial tests a new treatment called VET3-TGI, a virus designed to infect and kill cancer cells. It is given alone or with an immunotherapy drug (atezolizumab) to about 60 adults with advanced solid tumors that have not responded to standard treatments. The main go…

This study tests whether adding the immunotherapy drug camrelizumab to standard chemotherapy can help prevent cervical cancer from returning after surgery. It is for patients whose cancer has spread to nearby lymph nodes. The goal is to see if this combination improves the chance…

This study tests whether adding the drug tarlatamab to standard radiation is safe and effective for cancers that have a protein called DLL3. About 30 adults with cancers like melanoma, lung cancer, or glioblastoma will receive the combination. The goal is to find the best timing …

This early-phase study tests a new drug called BL-M07D1 in adults with advanced HER2-positive solid tumors (including breast, lung, stomach, and ovarian cancers) that have not responded to at least two prior treatments. The main goals are to check the drug's safety, find the best…

This study looks at how well the drug T-DXd works for people with advanced HER2-positive solid tumors who have already tried other treatments and have no good options left. About 100 adults in the US will be followed to see if their tumors shrink or stop growing. The goal is to u…

This study tests a combination of two drugs, Sac-TMT and QL1706, in people whose cervical cancer has come back or spread. The goal is to see if the treatment can shrink tumors and help patients live longer. About 89 adults with certain types of cervical cancer will take part.

This study compares proton therapy to standard photon therapy for cervical cancer patients needing extended-field radiation. The goal is to see if proton therapy causes less severe lymphopenia (low white blood cell count) and improves survival and side effects. About 44 adults wi…

This study tests an experimental drug called MT-4561 in people with advanced solid tumors (like lung, breast, or pancreatic cancer) who have tried at least one prior therapy. The main goals are to find a safe dose and check for early signs of tumor shrinkage. About 27 adults will…

This study tests whether same-day HPV testing and treatment can help prevent cervical cancer in 600 women living with HIV in the Dominican Republic. Cervical cancer is a leading cause of death in these women, but it is preventable with early detection. The goal is to see if this …

This study compares a shorter, higher-dose radiation schedule (hypofractionated) to the standard longer schedule for women with locally advanced cervical cancer. All participants also receive chemotherapy and internal radiation. The goal is to see if the shorter schedule is as sa…

This study looks at whether removing enlarged lymph nodes before standard chemoradiation helps people with stage IIICr cervical cancer live longer without the cancer growing. About 452 participants will be randomly assigned to either have lymph node surgery followed by chemoradia…

This study tests whether two drugs, pembrolizumab and lenvatinib, can slow tumor growth in people with cervical cancer that has come back or spread. About 30 adults with certain types of cervical cancer will receive the combination. The goal is to see if the treatment shrinks or …

This early-stage study tests an experimental injection called TI-0093 in 12 people with HPV-16 positive cancers (like head and neck or cervical cancer) that have returned or spread. The main goals are to check safety, find the best dose, and see how the body responds. It is not a…

This early-phase trial tests a new drug called MDX2001 in about 285 adults with advanced solid tumors (cancers that have spread). The main goals are to check the drug's safety and find the right dose. Researchers will also see if it shrinks tumors. This is not a cure, but it may …

This study tests two experimental drugs, ZG005 and gecacitinib, with or without bevacizumab, in people with advanced cervical cancer. The goal is to see if the combination is safe and can shrink tumors. About 120 women aged 18-75 with confirmed advanced cervical cancer will take …

This study tests whether a single dose of a patient's own genetically modified immune cells (E7 TCR-T cells) can shrink or eliminate HPV-related cancers before standard treatment like chemo-radiation or surgery. About 15 adults with advanced HPV-positive cancers (e.g., cervical, …

This study is testing a new robotic surgery system (Medtronic Hugo™) for hysterectomy, a surgery to remove the uterus. It includes 70 adult patients with conditions like fibroids, endometriosis, or certain cancers. The goal is to see if the robot can perform the surgery safely an…

This study tests whether a non-invasive physical plasma treatment can clear HPV infections from the cervix. About 50 adults with HPV will receive the treatment, and researchers will check if the virus is gone afterward. If successful, this approach could help prevent cervical can…

This study tests an experimental drug called YL202 in about 100 people with advanced solid tumors, including lung, colorectal, and cervical cancers that have not responded to other treatments. The main goal is to see if the drug can shrink tumors, while also checking for side eff…

This early-phase study tests a new drug called 177LuBetaBart in people with advanced solid tumors that have stopped responding to standard treatments. The drug is a radioactive antibody designed to seek out and destroy cancer cells. The study will check for safety and side effect…

This study tests a new drug called MK-2870 (sacituzumab tirumotecan) against standard treatments for people with cervical cancer that has returned or spread and has not responded to prior therapy. About 686 participants will be randomly assigned to receive either MK-2870 or a tre…

This early-phase study tests whether a new drug called NRM-823 is safe and tolerable for people with advanced solid tumors that have not responded to other treatments. About 150 participants with cancers like lung, ovarian, or triple-negative breast cancer will receive NRM-823 al…

This early-phase study tests a new drug called STRO-004 in adults with advanced solid tumors that have not responded to standard treatments. The study has three parts: finding a safe dose of STRO-004 alone, testing that dose in more patients, and combining STRO-004 with another c…

This study tests a new drug, BMS-986340, alone or with other cancer treatments (nivolumab or docetaxel) in people with advanced solid tumors that have worsened after standard therapy. The goal is to find safe doses and understand side effects. About 949 adults with various cancer…

This study tests whether adding a targeted radiation boost to the tumor during standard pelvic radiation helps shrink large cervical cancers more before internal radiation (brachytherapy). About 17 adults with bulky squamous cell cervical cancer will receive the extra boost. Rese…

This study tests whether adding an experimental drug (PRGN-2009) to the existing immunotherapy pembrolizumab can shrink tumors in people with advanced cervical cancer that no longer responds to pembrolizumab alone. About 24 adults with HPV-positive, recurrent or metastatic cervic…

This study tests a new radiation technique for people with cervical cancer or pelvic cancer that has come back. It is for those who cannot get standard brachytherapy because of unusual anatomy or large tumors. The goal is to see if this method can control the cancer in the treate…

This early-stage study tests a new drug, enzelkitug, given alone or with standard immunotherapy drugs, in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check safety and find the right dose. About 450 adults with cancers like lung, …

This early-phase study is testing an experimental drug called DR-0202 in people with advanced solid tumors (like breast, lung, or pancreatic cancer) that have stopped responding to standard treatments. The main goal is to check the drug's safety and find the right dose. About 96 …

This study tests a new experimental drug called GI-101, given alone or with other cancer drugs (pembrolizumab or lenvatinib), in people with advanced solid tumors that have spread. The goal is to see if the drug is safe and can shrink or control tumors. About 317 adults with canc…

This study tests two drugs, VS-6766 and defactinib, in people with certain gynecological cancers that have come back. The goal is to see if the combination can shrink tumors and how safe it is. About 55 adults with specific gene mutations (RAS, BRAF, or NF1) will take part.

This study tests whether adding the drug serplulimab to standard chemoradiotherapy helps people with locally advanced cervical cancer live longer without the disease getting worse. About 216 women aged 18-75 with untreated cervical cancer will take part. The main goal is to see i…

This study tests an experimental oral drug called NEO212 in adults with certain brain tumors (astrocytoma, glioblastoma) or cancers that have spread to the brain. The goal is to find the safest dose and see if it can slow tumor growth. About 134 participants will receive NEO212 a…

This early-phase study tests a new drug, KIVU-107, in about 76 adults with advanced solid tumors that have not responded to standard treatments. The drug is an antibody-drug conjugate designed to deliver a cancer-killing agent directly to tumor cells. The main goal is to find the…

This early-phase trial tests a new drug (ASTX660) combined with an immunotherapy (pembrolizumab) in people with advanced solid tumors, including triple-negative breast cancer and cervical cancer. The goal is to see if the combination is safe and can help the immune system recogni…

This study tests whether the drug belzutifan can shrink or slow the growth of clear cell cancers of the ovary, uterus, cervix, vagina, or vulva that have come back or not gone away. About 32 adults will receive belzutifan pills and be monitored for tumor response and side effects…

This early-stage study tests an experimental drug called NX-1607 in adults with advanced cancers that have not responded to standard treatments. The drug works by boosting the immune system to fight tumors. The main goals are to check safety and find the right dose, with a later …

This study tests a drug called ivonescimab in 50 people with advanced endometrial or cervical cancer that has worsened after standard chemotherapy. The drug targets two proteins (PD-1 and VEGF) to help the immune system fight the cancer and cut off its blood supply. The main goal…

This early-phase study tests an experimental oral drug, RGT-490, in adults with advanced solid tumors (including breast, ovarian, and endometrial cancers) that have a specific genetic change called PIK3CA. The main goals are to check safety, find the right dose, and see if the dr…

This study tests a new drug called volrustomig, either alone or with chemotherapy, in people with advanced or spreading solid tumors (cervical, head and neck, esophageal, or mesothelioma). The goal is to see if the drug can shrink tumors and control the disease. About 257 adults …

This early-phase study tests a new drug called BL-B01D1 in people with advanced lung cancer and other solid tumors that have spread or cannot be removed. The main goals are to check safety, find the best dose, and see if the drug shrinks tumors. About 470 adults will take part.

This study tests a new drug called CNSI-Fe(II), which is injected directly into tumors. It uses iron to trigger a type of cell death called ferroptosis, aiming to shrink or control advanced solid tumors like lung, pancreas, and colorectal cancer. About 54 adults whose cancers hav…

This study tests whether adding a vitamin A-like drug (ATRA) to a platelet-boosting medication (romiplostim N01) works better than the platelet drug alone for cancer survivors whose platelet counts stay low after chemotherapy. About 220 adults with gynecologic, breast, or lung ca…

This study tests a new drug called TER-2013 in people with advanced solid tumors (like breast, endometrial, ovarian, lung, head and neck, esophageal, or cervical cancer) that have specific changes in the AKT/PI3K/PTEN pathway. The goal is to see if the drug is safe and shrinks tu…

This early-stage study tests a new treatment called CD70-targeted CAR-T cells in people with advanced solid tumors, including kidney, lung, and ovarian cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have a specific marke…

This study tests a shorter course of radiation therapy combined with chemotherapy for cervical cancer. Normally, treatment takes 7-8 weeks, but this approach aims to finish in less time while still being effective. The trial includes 34 adults with advanced cervical cancer and wi…

This study tests an experimental drug called patritumab deruxtecan in people with advanced solid tumors that have spread or cannot be removed. The drug targets a protein called HER3 found on some cancer cells. About 740 adults with various cancers like lung, breast, or melanoma w…

This study tests a new drug called KRC-01, injected directly into the tumor, combined with standard radiation therapy for people with locally advanced cervical cancer. The trial has two parts: first, a small group to check safety and find the best dose; second, a larger group to …

This study tests a new drug called LY4052031 in people with advanced or spreading solid tumors, including bladder, breast, lung, and other cancers. The goal is to see if the drug is safe and works against these cancers. About 420 participants will take part, and the study will la…

This study tests two experimental drugs, BL-B01D1 and SI-B003, alone or together in 130 women with recurrent or metastatic cervical cancer that has not responded to standard treatments. The goal is to see if these drugs can shrink tumors or slow disease progression. Participants …

This study tests a new drug that delivers radiation directly to cancer cells with a specific marker (GRPR). It is for adults with advanced cancers like prostate, breast, lung, or colon cancer that have come back or spread. The main goal is to find a safe dose and check for side e…

This study aims to see if a Pap smear that women collect themselves is just as accurate as the traditional one done by a healthcare provider. Researchers will enroll 250 women aged 21-65 who need routine cervical cancer screening. If successful, this approach could make screening…

This study aims to create a test that can find endometrial, ovarian, and cervical cancers early using a sample of vaginal fluid or blood. Researchers will look for specific DNA markers and high-risk HPV in about 3,100 women. The goal is to make cancer detection easier and more ac…

This study is testing a small, AI-powered camera called the Pocket colposcope to see if it can accurately detect early signs of cervical cancer in women who have tested positive for HPV. About 1,054 women in Kenya will use the device during a routine exam. The goal is to find a s…

This study explores whether women can accurately collect their own samples to test for HPV, the virus that can cause cervical cancer. Researchers will compare results from two different self-collection kits to standard Pap smears. The goal is to make screening easier and more acc…

This study aims to see if a special light tool can find early signs of cervical cancer. Researchers will look at the light patterns from cervical tissue in 350 women who are already getting a colposcopy or treatment. The goal is to identify unique "optical signatures" of abnormal…

This study is testing a new type of PET scan that targets a protein called Trop2, found on many solid tumors. The goal is to see if this scan can find and stage cancers like bladder, lung, liver, and ovarian cancer better than current methods. About 400 adults with confirmed or s…

This study is testing a new blood test that looks for tiny pieces of HPV DNA shed by cervical cancer or pre-cancer cells. The goal is to see if this simple blood draw can tell the difference between early pre-cancer and invasive cancer, and help monitor patients without needing r…

This study looks at whether giving women a simple at-home kit to test for HPV (the virus that can cause cervical cancer) makes it easier for those who are overdue for screening to get tested. About 100 women aged 25-65 who haven't had a Pap smear in 3 years will receive a self-co…

This study is testing a blood test that looks for DNA signals from 20 different cancers, including lung, breast, and colon cancer. Researchers will see if the test can find cancer early and tell which type it is. In people with lung cancer, the test will also check for any cancer…

This study is testing a new type of PET/CT scan that uses a special tracer called 18F-T2 to find cancers that have high levels of a protein called CAIX. About 200 adults with cancers like kidney, bladder, lung, or breast cancer will get this scan to see if it works better than th…

This study compares two new technologies for detecting cervical cancer in Mozambique: a quick HPV test and a special imaging system. About 678 women aged 25-49 who have had an abnormal screening result will participate. The goal is to see if these tools are as accurate as current…

This study is testing a new, affordable way to screen for cervical cancer using artificial intelligence. It analyzes urine samples and cervical images to detect high-risk HPV and precancerous changes. The goal is to provide a one-stop screening and triage system that works in low…

This study tests whether a visit with a general practitioner can encourage more women to get screened for cervical cancer. About 11,200 women aged 25 to 65 in France who are behind on screening will take part. The goal is to see if a doctor's involvement increases screening rates…

This study tests a new care strategy called DADA LINK to help more women in Kenya get screened for cervical cancer and receive treatment if needed. About 1,980 women aged 25-49 will take part. The approach uses care coordinators and a mobile health platform to support clinics in …

This study tests a program to help prevent cervical cancer in women who have both HPV and HIV. The program includes HPV screening, nutritional support, and mental health help delivered by community health workers. Researchers will enroll 420 women in India to see if this approach…

This study looks at how effective the HPV vaccine is at preventing cervical HPV infection in women in Sikkim, India, about 7 years after the vaccination program started. Researchers will compare HPV infection rates in married women aged 18 to 22 now versus at the start of the pro…

This study aims to prevent unnecessary deaths from cervical cancer in Senegal by helping more women get screened early. Researchers will adapt a patient navigation program for both urban and rural areas, addressing barriers like stigma and misinformation. About 900 women and heal…

This study is testing whether offering a self-sampling kit for HPV (the virus that can cause cervical cancer) can encourage more women who haven't been screened in years to get tested. Researchers will compare different ways of offering the kit to find the best approach. The goal…

This early-phase study tests whether fecal microbiota transplantation (FMT) can safely reduce diarrhea and colon inflammation caused by immune-checkpoint inhibitors in people with genitourinary and other cancers. About 40 participants will receive FMT and be monitored for side ef…

This study is testing whether starting pelvic floor physical therapy soon after radiation treatment can reduce bowel and bladder problems in women with cervical cancer. Twenty-eight women who are getting radiation to the pelvis will begin therapy four weeks after their radiation …

This study tests whether using MRI to guide brachytherapy (internal radiation) for gynecologic cancers like cervical or uterine cancer can better target tumors and reduce radiation to nearby organs like the bladder and rectum. About 54 adults who are already eligible for standard…

This study is for people who have had surgery for cervical, uterine, or endometrial cancer and need radiation to the pelvis. It uses a precise type of proton radiation to see if it causes fewer bowel side effects than standard radiation. About 25 adults will take part.

This study looks at whether using the Headspace mindfulness app before surgery or chemoradiation can help patients with endometrial or cervical cancer use fewer opioids and feel better. About 120 participants will be randomly assigned to use the app or not. The goal is to see if …

This study tests whether Reiki, a gentle hands-on energy therapy, can reduce anxiety and pain in people receiving brachytherapy (internal radiation) for gynecologic cancers like endometrial, cervical, vaginal, or vulvar cancer. About 70 participants will be randomly assigned to r…

This study tests whether a special type of pelvic floor exercise, guided by biofeedback, can improve sexual function and pelvic health in women who had radiation for cervical cancer. Sixty survivors aged 30-60 will be randomly assigned to either biofeedback-assisted training or s…

This study compares a 1-week radiation schedule to a standard 6-8 week schedule for relieving pain in people with advanced cervical cancer that cannot be cured. The goal is to see if the shorter treatment provides faster and effective pain relief. About 230 participants will be e…

This study looks at possible eye-related side effects in people with cervical cancer that has returned or spread, who are being treated with the drug TIVDAK. About 100 participants will receive TIVDAK every three weeks and undergo regular eye exams before, during, and after treat…

This study tests a new way to deliver radiation for cervical cancer. Instead of using one fixed plan for weeks, an AI adjusts the radiation daily based on the tumor's position, and weekly MRI scans provide extra guidance. The goal is to reduce side effects like bladder and bowel …

This study looks at the best times to send messages encouraging physical activity to older cancer survivors (age 65+) who have chronic pain. Researchers will track activity levels and pain ratings to see how messages affect movement and pain episodes. The goal is to learn how to …

This study looks at whether changes in a blood marker called CRP can help predict how well immunotherapy works in women with advanced gynecologic cancers (cervical, endometrial, ovarian, or vulvar). Researchers will track CRP levels in 120 women receiving immunotherapy plus chemo…

This study is testing two blood tests that look for HPV DNA and RNA to see if they can track how well cervical cancer responds to surgery, radiation, and chemotherapy. About 55 adults with HPV-related cervical cancer will give blood samples before and after treatment. The goal is…

This study looks at whether peer-to-peer education and support can help more young people (ages 15-39) living with HIV get screened for and treated for certain cancers. About 4,100 participants in Zambia will take part. The goal is to see if this approach increases the number who…

This study looks at better ways to provide cervical cancer screening and treatment to women living with HIV in Nigeria. About 2,400 women will take part. The goal is to see which methods work best to get more women screened and treated, ultimately improving their health and life …

This study looks at immune cells (T cells) in tumor samples from 1,100 people with cancers like head and neck, ovarian, cervical, lung, and brain cancer. Researchers want to understand how these cells behave, especially a protein called PD-1. No new treatments are tested—only sam…

This study is testing whether HPV DNA found in blood and urine can be used to detect cervical cancer and monitor how well treatment is working. Researchers will collect samples from 30 women newly diagnosed with cervical cancer before and after treatment. The goal is to see if th…

This study is testing a program called CARES that provides advocacy, resources, education, and support to rural cancer patients. The goal is to see if it helps them start treatment sooner and finish it on time. About 320 adults with solid tumors like lung, breast, or colon cancer…

This study is testing whether a liquid biopsy (a blood or fluid test) can effectively monitor HPV-related cancers like cervical and throat cancer. Researchers will follow 480 patients for 4 years, collecting samples before, during, and after treatment to see if the test can detec…

This study tests whether women in war-torn Ukraine can screen for cervical cancer using a simple self-sampling kit for HPV. About 1,000 women aged 30-60 will collect their own samples at home and send them to a lab. The goal is to see if this approach works during conflict and he…

This study tests different strategies to help people with cervical cancer start treatment sooner in Botswana. Researchers will enroll 610 women aged 18 and older who have been diagnosed with invasive cervical cancer. The goal is to see which approaches work best to begin treatmen…

This study looks at whether HPV DNA can be found in the blood of people with HPV-related anal or cervical cancer before, during, and after radiation therapy. Researchers will collect blood samples and tumor tissue to see if changes in HPV DNA levels can help predict if the cancer…

This early-phase study is testing a new substance called RAD301 to see how it moves through the body and how much radiation it gives off. It involves 9 people: healthy volunteers and patients with certain cancers like pancreatic, lung, or ovarian cancer. The goal is to measure sa…

This study tests whether a newer type of scan, PET/MRI, is better than the standard PET/CT at finding cancer spread to lymph nodes in people with locally advanced cervical cancer. About 50 adults with stage IB2 to IVA cervical cancer will receive both scans before treatment. The …

This study is collecting tumor, blood, and plasma samples from over 1,000 people with certain cancers (ovarian, breast, head and neck, cervical, vulva, and sarcoma). The goal is to find new markers that link tumor genetics and immune response to how the disease behaves. Participa…

This study looks at how the amount and storage of a dye called indocyanine green (ICG) affect its ability to find sentinel lymph nodes in people with cervical, endometrial, or vulvar cancer. The goal is to find the most effective and cost-saving way to use ICG during surgery. Abo…

This study tests whether artificial intelligence can help more women in the Occitanie region of France complete cervical cancer screening. Researchers will send HPV self-sampling kits to 3000 women aged 30-65 who haven't been screened recently. The goal is to see if AI-assisted r…

This study looks at whether a special PET scan and a blood test for HPV can find leftover cancer cells in people with cervical cancer after they finish standard chemoradiation. About 64 adults with stage IB-IVA cervical cancer will take part. The goal is to see how well these tes…

This study looks at whether offering cervical cancer screening together with family planning services helps more women get screened. About 14,600 women aged 30-49 or those living with HIV in two regions of Mozambique will take part. The goal is to see if combining these services …

This study aims to understand how the tumor's surroundings change during chemoradiotherapy for locally advanced cervical and pancreatic cancers. Researchers will collect tissue and blood samples before, during, and after treatment from about 60 participants. The goal is to learn …

This study is testing a mobile health tool called mSaada to help community health workers screen women for cervical cancer in western Kenya. Researchers will work with 6,000 women and health volunteers to see if the app makes screening easier and more effective. The goal is to fi…

This study is testing a new device called the Calla introducer to see if women prefer it over the standard speculum during cervical cancer screening. Researchers will interview and survey about 305 healthy women aged 21-65 to gather their opinions. The goal is to improve the scre…

This study looks at whether people with certain cancers prefer getting their immunotherapy (nivolumab or pembrolizumab) as a shot under the skin or as an IV drip. About 880 patients will try both methods and say which they like better. The goal is to understand patient preference…